FIRST AIRED: May 23, 2017

Nice work! Enjoy the show!

×

You’re busy. We get it.

Stay on top of the news with our Editor’s Picks newsletter.

US Edition
Intl. Edition
Unsubscribe at any time. One click, it’s gone.

Thanks for signing up!

×

Transcript

00:00:00
mn new diabetes drug has doctors patients and investors all excited after study showed surprising life saving results , the only ones not particularly thrilled are the U. S. health insurers , reddit healthcare correspondent Caroline humor explains why US health insurers are encouraging doctors to , sort of , forty eight hundred , compared to the , that might brand , that's been a hundred dollars thirteen weeks ago in the study came out that showed that it actually , cut cardiovascular deaths by about one third that got the market pretty excited Lilly shares went up ten percent in one day but insurers like Aetna and CBSA further studies need doing , a process that could take several more years one of the reasons why insurers are not increasing drug right off the bat is because the study showed that it came to live with it , it didn't actually show how it did it it's actually mystery not has given insurance a little pot well it's a legitimate concern humor says it's also a familiar one for insurers their insurance and I we get a little bit of pressure back on track that's what they do with it it's standard fare but in the last couple years between them really after NASA how they do that to the issue printers really in that we have had a little bit of skepticism about why did Sean does what it does they want to see anything , to the them at a time when , there's a lot of attention I'm keeping , meeting the twenty four million people living with type two diabetes will have to wait a bit longer for their insurance to cover JRD